These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4921481)

  • 1. Effects of immunity on transmission of influenza: experimental studies.
    Schulman JL
    Prog Med Virol; 1970; 12():128-60. PubMed ID: 4921481
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunity status of the Milanese population towards B-Hong Kong-8-73, the new B type strain and study of the immunizing activity of the old composition vaccine].
    Profeta ML; Zanetti AR; Bergamini F
    Boll Ist Sieroter Milan; 1973; 52(5):429-35. PubMed ID: 4788200
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of antibodies to neuraminidase of A2-Hong Kong and A2-Taiwan influenza viruses after administration of different Hong Kong vaccines and after natural infection in humans.
    Závadová H
    Acta Virol; 1973 Jul; 17(4):287-92. PubMed ID: 4148207
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of antineuraminidase antibody in immunity to influenza virus infection.
    Schulman JL
    Bull World Health Organ; 1969; 41(3):647-50. PubMed ID: 5309490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza: antigenic spectrum.
    Pereira HG
    Prog Med Virol; 1969; 11():46-79. PubMed ID: 4906872
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of preinfection and preimmunization on the serum antibody response to subsequent immunization with heterotypic influenza vaccines.
    Jennings R; Potter CW; McLaren C
    J Immunol; 1974 Dec; 113(6):1834-43. PubMed ID: 4547776
    [No Abstract]   [Full Text] [Related]  

  • 7. On the epidemiology of influenza. I. Pre-epidemic antibody levels and their relation to some epidemiological characteristics of influenza.
    Farnik J; Bruj J; Skocil V
    Zentralbl Bakteriol Orig; 1969; 211(4):445-52. PubMed ID: 5386503
    [No Abstract]   [Full Text] [Related]  

  • 8. Specificity of the local secretory antibody to influenza A virus infection.
    Richman DD; Murphy BR; Tierney EL; Chanock RM
    J Immunol; 1974 Nov; 113(5):1654-6. PubMed ID: 4213978
    [No Abstract]   [Full Text] [Related]  

  • 9. Antineuraminidase antibody response of man to influenza virus neuraminidase N2: results obtained with an improved hemagglutination inhibition technique and an enzyme inhibition test.
    Hennessy AV; Minuse E; Davenport FM
    J Immunol; 1972 Aug; 109(2):213-6. PubMed ID: 5047368
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antineuraminidase antibodies in influenza infection and vaccination with inactivated vaccines].
    Profeta ML; Zanetti A; Bergamini F
    Boll Ist Sieroter Milan; 1972; 51(3):190-9. PubMed ID: 4653136
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immune responses and detection methods in influenza infections (author's transl) (proceedings)].
    Z Erkr Atmungsorgane; 1979; 152(1):95-104. PubMed ID: 433332
    [No Abstract]   [Full Text] [Related]  

  • 12. Association of serum anti-neuraminidase antibody with resistance to influenza in man.
    Murphy BR; Kasel JA; Chanock RM
    N Engl J Med; 1972 Jun; 286(25):1329-32. PubMed ID: 5027388
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of influenza virus hemagglutinin, neuraminidase and their antibody responses in infected patients.
    Chen SH; Huang CH; Yang YJ; Hsia S
    Taiwan Yi Xue Hui Za Zhi; 1973 Jun; 72(6):319-24. PubMed ID: 4519978
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibody response in man to influenza virus neuraminidase following influenza.
    Kilbourne ED; Christenson WN; Sande M
    J Virol; 1968 Jul; 2(7):761-2. PubMed ID: 5723531
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibody response to influenza virus enzyme in man.
    Davenport FM; Minuse E; Hennessy AV
    Arch Environ Health; 1970 Sep; 21(3):307-11. PubMed ID: 5504431
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlated studies of a recombinant influenza-virus vaccine. II. Definition of antigenicity in experimental animals.
    Schulman JL; Kilbourne ED
    J Infect Dis; 1971 Nov; 124(5):463-72. PubMed ID: 5115670
    [No Abstract]   [Full Text] [Related]  

  • 17. Influenza anti-neuraminidase: the second best antibody.
    Dowdle WR
    N Engl J Med; 1972 Jun; 286(25):1360-1. PubMed ID: 5027391
    [No Abstract]   [Full Text] [Related]  

  • 18. [Influenza vaccination. The importance of antigen amount and adjuvant with reference to the humoral antibody formation after influenza vaccination. A comparative double-blind study with various vaccines].
    Sarateanu DE; Ehrengut W
    Fortschr Med; 1981 Sep; 99(34):1348-52. PubMed ID: 7026399
    [No Abstract]   [Full Text] [Related]  

  • 19. [Reaction of influenza viruses with thymus-dependent lymphocytes].
    Süss J; Schmidt S; Schmidt J
    Allerg Immunol (Leipz); 1982; 28(3):165-73. PubMed ID: 6183963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of partial immunity to influenza by a neuraminidase-specific vaccine.
    Couch RB; Kasel JA; Gerin JL; Schulman JL; Kilbourne ED
    J Infect Dis; 1974 Apr; 129(4):411-20. PubMed ID: 4593871
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.